4-methyl-3-(phenylsulfonyl)furoxan has been researched along with molsidomine in 1 studies
Studies (4-methyl-3-(phenylsulfonyl)furoxan) | Trials (4-methyl-3-(phenylsulfonyl)furoxan) | Recent Studies (post-2010) (4-methyl-3-(phenylsulfonyl)furoxan) | Studies (molsidomine) | Trials (molsidomine) | Recent Studies (post-2010) (molsidomine) |
---|---|---|---|---|---|
5 | 0 | 0 | 2,022 | 148 | 143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosia, A; Bussolino, F; Calvino, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, GP; Till, U | 1 |
1 other study(ies) available for 4-methyl-3-(phenylsulfonyl)furoxan and molsidomine
Article | Year |
---|---|
Activation of endothelial guanylate cyclase inhibits cellular reactivity.
Topics: Arachidonic Acid; Cell Adhesion; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Guanylate Cyclase; Humans; Molsidomine; Nitric Oxide; Nitroprusside; Oxadiazoles; Platelet Activating Factor; Thrombin; Umbilical Veins | 1995 |